Janus Henderson Group PLC Satsuma Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$3.85 - $28.47 $210,337 - $1.56 Million
-54,633 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$16.01 - $34.69 $155,985 - $337,984
-9,743 Reduced 15.13%
54,633 $1.57 Million
Q1 2020

May 14, 2020
BUY
$14.53 - $30.69 $736,264 - $1.56 Million
50,672 Added 369.76%
64,376 $1.38 Million
Q4 2019

Feb 18, 2020
BUY
$9.32 - $19.68 $127,721 - $269,694
13,704 New
13,704 $269,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email